A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...
Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the United States. To confirm the diagnosis, biopsies are required. A team of researchers has now ...
The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—has published a new book explaining ...
ORLANDO, Fla. (Ivanhoe Newswire) - Prostate cancer is the second leading cause of death in men right behind heart disease. Patients with this cancer often don’t find out until the disease has advanced ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, and University College London (UCL) today announced that data published online in ...
Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...
Black men have a higher risk of prostate cancer. Surgery is sometimes the best treatment option for certain tumors. MSK ...
Dr. Ash Tewari launched a testing facility on wheels that’s screened more than 10,000 men for prostate cancer. His goal? One ...
Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...
An informational website and a mobile testing van in Philadelphia are making it easier to learn about cancer and get tested. Hall of Fame running back Emmitt Smith will be hosting a series of short ...